Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 MANAGEMENT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET MANAGEMENT COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: LAWS AND REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING PATIENT POPULATION SUFFERING FROM NEONATAL JAUNDICE
5.1.2 LARGE NUMBER OF RISK FACTORS
5.1.3 RISING NUMBER OF NEW-BORN INFANTS
5.1.4 INCREASE IN PRETERM BIRTH
5.1.5 AWARENESS ABOUT NEONATAL JAUNDICE AMONG THE POPULATION
5.2 RESTRAINTS
5.2.1 SIDE-EFFECTS RELATED TO PHOTOTHERAPY
5.2.2 PRODUCT RECALLS
5.2.3 LIMITED ADOPTION OF NEONATAL JAUNDICE MANAGEMENT
5.3 OPPORTUNITIES
5.3.1 INCREASING HEALTHCARE EXPENDITURE
5.3.2 TECHNOLOGICAL ADVANCEMENT IN DIAGNOSIS AND TREATMENT
5.3.3 INCREASING DISPOSABLE INCOME
5.3.4 INCREASE IN AGREEMENTS AND ACQUISITIONS
5.4 CHALLENGES
5.4.1 COMPLICATIONS RELATED TO NEONATAL JAUNDICE
5.4.2 LACK OF SKILLED PROFESSIONALS
5.4.3 DIAGNOSIS OF NEONATAL JAUNDICE
6 COVID-19 IMPACT ON MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET IN HEALTHCARE INDUSTRY
6.1 PRICE IMPACT
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 STRATEGIC DECISION FOR MANUFACTURERS / SERVICE PROVIDERS
6.5 CONCLUSION
7 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT
7.1 OVERVIEW
7.2 DIAGNOSIS
7.2.1 TRANSCUTANEOUS BILIRUBINOMETER (TCB)
7.2.2 TOTAL SERUM BILIRUBIN (TSB)
7.2.3 VISUAL ASSESSMENT
7.3 TREATMENT
7.3.1 PHOTOTHERAPY
7.3.1.1 LED PHOTOTHERAPY
7.3.1.2 FIBREOPTIC PHOTOTHERAPY
7.3.1.3 CONVENTIONAL PHOTOTHERAPY
7.3.1.3.1 CONVENTIONAL PHOTOTHERAPY WITH COMPACT FLUORESCENT LAMP
7.3.1.3.2 CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP
7.3.1.3.2.1 FULL-BODY PHOTOTHERAPY
7.3.1.3.2.2 PARTIAL-BODY PHOTOTHERAPY
7.3.2 EXCHANGE TRANSFUSION
7.3.3 INTRAVENOUS IMMUNOGLOBULIN
7.3.4 OTHERS
8 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE
8.1 OVERVIEW
8.2 PRIMARY CARE
8.3 SECONDARY CARE
9 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY
9.1 OVERVIEW
9.2 LIGHT-EMITTING DIODE LIGHT SOURCES
9.3 FIBEROPTIC
9.4 FLUORESCENT
9.5 HALOGEN
10 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 CLINICS
10.4 HOME USERS
10.5 AMBULATORY SURGICAL CENTERS
10.6 OTHERS
11 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 RETAIL SALES
11.4 THIRD PARTY DISTRIBUTION
12 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET BY GEOGRAPHY
12.1 MIDDLE EAST AND AFRICA
12.1.1 SOUTH AFRICA
12.1.2 SAUDI ARABIA
12.1.3 UAE
12.1.4 ISRAEL
12.1.5 EGYPT
12.1.6 REST OF MIDDLE EAST AND AFRICA
13 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
14 SWOT
15 COMPANY PROFILES
15.1 SIGNIFY HOLDING
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE FINANCIALS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
15.2.1 COMPANY SNAPSHOT
15.2.2 RECENT FINANCIALS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 ATOM MEDICAL CORP.
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS
15.4 NATUS MEDICAL INCORPORATED
15.4.1 COMPANY SNAPSHOT
15.4.2 RECENT FINANCIALS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 DRAGERWERK AG & CO. KGAA
15.5.1 COMPANY SNAPSHOT
15.5.2 RECENT FINANCIALS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 HERBERT WALDMANN GMBH & CO. KG
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 AEROFLOW, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ARDO
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 AVIHEALTHCARE
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 BRAUN & CO. LIMITED
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 DAVID
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 GINEVRI SRL
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 IBIS MEDICAL
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 NEOLIGHT
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 NEOMEDLIGHT
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
15.16 NICE NANOTECH MEDICAL SYSTEMSPVT. LTD.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.17 PHOENIX MEDICAL SYSTEMS (P) LTD
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 S S TECHNOMED (P) LTD
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 SHVABE ZURICH GMBH
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 WEYER GMBH
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
15.21 ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 REGULATION IMPOSED BY SEVERAL REGULATORY AGENCIES IN DIFFERENT REGIONS
TABLE 2 RISK FACTORS FOR NEONATAL JAUNDICE
TABLE 3 CHARACTERISTICS OF TERM AND PRETERM INFANTS
TABLE 4 HEALTHCARE EXPENDITURE IN ASIA
TABLE 5 QUESTIONNAIRE FOR THE ONLINE FOLLOW-UP
TABLE 6 TIME SCHEDULE OF ONLINE FOLLOW-UP AFTER DISCHARGE
TABLE 7 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA PRIMARY CARE IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA SECONDARY CARE IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA LIGHT-EMITTING DIODE LIGHT SOURCES IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA FIBEROPTIC IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA FLUORESCENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA HALOGEN IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA HOSPITALS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CLINICS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA HOME USERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA OTHERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA DIRECT TENDERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA RETAIL SALES IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTION IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 51 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 52 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 60 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 62 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 63 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 65 UAE DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 66 UAE TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 67 UAE TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 68 UAE TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 69 UAE TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 70 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 71 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 72 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 73 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 74 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 75 ISRAEL DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 76 ISRAEL TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 77 ISRAEL TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 78 ISRAEL TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 79 ISRAEL TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 80 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 83 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 84 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 85 EGYPT DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 86 EGYPT TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 87 EGYPT TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 88 EGYPT TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 89 EGYPT TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 90 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 91 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 92 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 93 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 94 REST OF MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: MIDDLE EAST AND AFRICA VS. REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: MARKET MANAGEMENT COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA BRONCHIECTASIS MARKET: SEGMENTATION
FIGURE 12 RISING PATIENT POPULATION SUFFERING FROM NEONATAL JAUNDICE IS DRIVING THE MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 MANAGEMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET
FIGURE 15 GRAPHICAL REPRESENTATION FOR NUMBER OF CHILDBIRTH ON THE BASIS OF DIFFERENT REGIONS
FIGURE 16 GRAPHICAL REPRESENTATION FOR NUMBER OF PRETERM CHILDBIRTH FOR DIFFERENT COUNTRIES
FIGURE 17 HEALTH SPENDING BY MAJOR NUMBER OF FUNDS
FIGURE 18 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, 2021
FIGURE 19 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, 2019-2028 (USD MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, CAGR (2021-2028)
FIGURE 21 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, LIFELINE CURVE
FIGURE 22 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, 2021
FIGURE 23 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 25 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, 2021
FIGURE 27 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, 2019-2028 (USD MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 29 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, 2021
FIGURE 31 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 33 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 35 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 36 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 37 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: SNAPSHOT (2020)
FIGURE 39 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY COUNTRY (2020)
FIGURE 40 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT (2021-2028)
FIGURE 43 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)
